International Scholarly Research Notices / 2012 / Article / Tab 1 / Review Article
A New Strategy to Find Targets for Anticancer Therapy: Chemokine CXCL14/BRAK Is a Multifunctional Tumor Suppressor for Head and Neck Squamous Cell Carcinoma Table 1 CXC Chemokine ligands and their receptors.
Systematic name CXC Chemokine Chemokine receptor Function Human Mouse ELR + chemokines CXCL1 MGSA-
/GRO-
GRO/MIP-2 CXCR2 > CXCR1 P CXCL2 MGSA-
/GRO-
GRO/MIP-2 CXCR2 P CXCL3 MGSA-
/GRO-
GRO/MIP-2 CXCR2 P CXCL5 ENA-78 GCP2/LIX? CXCR2 P CXCL6 GCP-2 GCP2/LIX? CXCR1, CXCR2 P CXCL7 NAP-2 CRA-a,b CXCR2 P CXCL8 IL-8 Unknown CXCR1, CXCR2 P ELR − chemokines CXCL4 PF-4 PF-4 CXCR3A and B A/S CXCL9 Mig Mig CXCR3 A CXCL10 IP-10 IP10CRG2 CXCR3 A CXCL11 I-TAC I-TAC CXCR3 A CXCL12 SDF-1
/
SDF1/PBSF CXCR4, CXCR7 M, P CXCL13 BCA-1 BLC CXCR5 ? CXCL14 BRAK BRAK (BMAC) ? A/N/S CXCL16 SR-PSOX CXCL16 CXCR6 NT/S
A: angiostatic, M: metastatic, N: NK cell regulation, NT: NKT cell regulation, P: tumor progression, S: tumor suppression.